Shlomo Shinnar, John M Pellock. Show Affiliations »
Abstract
Mesh： See more » Age FactorsAnticonvulsants/administration & dosageAnticonvulsants/adverse effectsAnticonvulsants/pharmacokineticsBrain/drug effectsBrain/physiopathologyCarbamazepine/administration & dosageCarbamazepine/adverse effectsCarbamazepine/analogs & derivativesCarbamazepine/pharmacokineticsChildClinical Trials as Topic/standardsDrug-Related Side Effects and Adverse ReactionsEpilepsy/drug therapyHumansMonitoring, Physiologic/standardsMonitoring, Physiologic/trendsOxcarbazepinePediatrics/standardsPharmacology, Clinical/standardsSelection Bias
Substances： See more » AnticonvulsantsCarbamazepineOxcarbazepine
Year: 2005 PMID： 16275818 DOI： 10.1212/01.wnl.0000183475.81594.29
Source DB: PubMed Journal: Neurology ISSN： 0028-3878 Impact factor: 9.910